+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prediction of free levels of phenytoin and carbamazepine in patients comedicated with valproic acid



Prediction of free levels of phenytoin and carbamazepine in patients comedicated with valproic acid



Therapeutic Drug Monitoring 17(4): 327-332



Serum samples from patients receiving phenytoin (PHT) or carbamazepine (CBZ) and sodium volproate (VPA) polytherapy were filtered at 37 degrees C and the free concentrations were measured by high-performance liquid chromatography. The mean apparent dissociation constants (KD) for the binding of PHT and CBZ to albumin were calculated. The mean KD values were used to predict free levels of PHT or CBZ in serum from patients also taking VPA, based on information about the total serum concentrations of the drugs and albumin. In the presence of VPA the values of the free fraction (alpha) for PHT and CBZ increased and the values for the apparent dissociation constants (KD) decreased compared with the situation of monotherapy. These decreases in the value of KD and increases in the value of alpha were statistically significant. The correlations between values for predicted and analysed free levels of PHT or CBZ were close, with r values of 0.999 and 0.998, respectively. The mean prediction error was small, 0.01 +/- 0.22 mumol/L for PHT and 0.03 +/- 0.42 mumol/L for CBZ. The percentage differences between predicted and observed free levels for PHT and CBZ were < 10%. We conclude that our method of prediction is sufficiently accurate and precise for clinical use.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009227881

Download citation: RISBibTeXText

PMID: 7482684

DOI: 10.1097/00007691-199508000-00002


Related references

Derivation and evaluation of an equation for prediction of free carbamazepine concentration in patients comedicated with valproic acid. Therapeutic Drug Monitoring 11(5): 528-532, 1989

Prediction of the free serum concentrations of phenytoin phenobarbital carbamazepine and carbamazepine 10 11 epoxide in patients on valproic acid co medication. Sunshine, I (Ed ) Recent Developments in Therapeutic Drug Monitoring And Clinical Toxicology; Second International Conference on Tdm (Therapeutic Drug Monitoring)-Toxicology, Barcelona, Spain Xii+791p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 401-407, 1992

Analytical evaluation and validation of ADVIA Centaur competitive immunoassay for measurement of free Valproic Acid, Carbamazepine and Phenytoin levels. Clinical Chemistry 50(6, Suppl S, Part 2): A129, June, 2004

Estimation vs determination of fraction of free drug of phenytoin , valproic acid and carbamazepine in patients on monotherapy. Clinical Chemistry & Laboratory Medicine 37(SPEC SUPPL ): S317, June, 1999

Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients comedicated with valproate. Epilepsia 29(5): 655, 1988

Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid. Therapeutic Drug Monitoring 11(2): 134-139, 1989

Effect of valproic acid on free phenytoin levels in epileptic patients. Wada, J A And J K Penry (Ed ) Advances in Epileptology, Vol 10 Epilepsy International Symposium, Vancouver, B C , Canada, 1978 Xxxiii+523p Raven Press: New York, N Y , Usa Illus Maps P354-355, 1980

The effects of valproic acid, carbamazepine and phenytoin on the levels of neuropeptide Y in five brain regions. Society for Neuroscience Abstracts 26(1-2): Abstract No -272 3, 2000

Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations. Therapeutic Drug Monitoring 21(4): 421-425, 1999

Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid. European Neurology 31(1): 57-60, 1991

The number of serum concentration levels per person in elderly nursing home residents on phenytoin, carbamazepine, and valproic acid. Epilepsia 40(SUPPL 2): 280, 1999

Pharmacokinetic interaction between valproic acid, topiramate, phenytoin or carbamazepine and retigabine in epileptic patients. Clinical Pharmacology & Therapeutics 69(2): P18, February, 2001

Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients. Basic & Clinical Pharmacology & Toxicology 99(2): 133-140, 2006

Significance of free phenytoin level measurement in epileptic patients receiving concurrent treatment with phenytoin and valproic acid. Journal of Tokyo Women's Medical College 56(10-11): 991-997, 1986